208
Participants
Start Date
June 14, 2023
Primary Completion Date
November 30, 2024
Study Completion Date
April 30, 2025
Rituximab
Rituximab 1000 mg in 150 ml 0,9 % NaCl (total volume of infusion 250 ml)
MabThera®
MabThera® 1000 mg in 150 ml 0,9 % NaCl (total volume of infusion 250 ml)
Immanuel Kant Baltic Federal University, Kaliningrad
Scientific-Research Medical Complex Your Health, Kazan'
"LLC Medical Center Revma-Med", Kemerovo
"LLC Korolev Family Clinic №4", Korolyov
Moscow City Clinical Hospital №1, Moscow
V.A. Nasonova Research Institute of Rheumatology, Moscow
Orenburg State Medical University, Orenburg
"JSC Northwestern Center for Evidence-Based Medicine", Saint Petersburg
"LLC Interleukin", Saint Petersburg
"Medical center Capital-Polis", Saint Petersburg
Saratov State Medical University, Saratov
"LLC Biomed", Vladimir
Mabscale, LLC
INDUSTRY